Skip to main content

Month: June 2020

Methode Electronics to Announce Fourth Quarter and Full Year Fiscal 2020 Results on Tuesday, June 30, 2020

CHICAGO, June 22, 2020 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a global developer of custom engineered and application specific products and solutions, today announced it will release its fourth quarter and full year Fiscal 2020 results for the period ended May 2, 2020, on Tuesday, June 30, 2020, before the market opens.Following the release, the company will conduct a conference call and webcast to review financial and operational highlights led by its President and Chief Executive Officer, Donald W. Duda, and Chief Financial Officer, Ron Tsoumas, at 10:00 a.m. CDT.To participate in the conference call, please dial (844) 369-8770 (domestic) or (862) 298-0840 (international) at least five minutes prior to the start of the event. A simultaneous webcast can be accessed through the company’s website, www.methode.com,...

Continue reading

Introducing the Verizon Visa Card, a new way for Verizon customers to save on their bill

What you need to know:Use your Verizon Visa Card® everywhere it’s accepted to earn Verizon Dollars – rewards you can redeem for the best things at Verizon. Spend 1 Verizon Dollar on Verizon purchases just like you’d spend $1 US Dollar. No limits on how much you can earn, no expiration date. The Verizon Visa Card, exclusively offered to Verizon wireless customers, is the only credit card that is eligible for the Auto Pay discount on Verizon, so new Auto Pay enrollees can get the best pricing available on Verizon Unlimited plans.It’s worth its weight in rewards. For everyday purchases at grocery stores and dining, including delivery and pick up, cardholders will earn accelerated rewards to help save on their Verizon bill or on the newest technology.Customers can add the card to their mobile wallets for digital, contactless-use or...

Continue reading

Carbon Nanotubes Market to reach USD 13.65 Billion by 2026; Demand for Sustainable Products will Open up a Huge Potential for Market Growth, says Fortune Business Insights™

Pune, June 22, 2020 (GLOBE NEWSWIRE) — The global carbon nanotubes market size is projected to reach USD 13.65 billion by the end of 2026. The increasing investment in development of sustainable solar cells will bode well for the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Carbon Nanotubes (CNT) Market Size, Share & Industry Analysis, By Product (Multi-Walled Carbon Nanotubes (MWCNT) and Single-Walled Carbon Nanotubes (SWCNT)), By Application (Plastics & Composites, Electrical & Electronics, Energy, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 4.56 billion in 2018 and will exhibit a CAGR of 15.3% during the forecast period, 2019-2026.COVID-19 Impact Analysis:The recent coronavirus outbreak has had a huge impact on business...

Continue reading

COMMUNIQUE DE PRESSE: NACON A INTÉGRÉ LES INDICES EURONEXT CAC SMALL, CAC MID & SMALL ET CAC ALL-TRADABLE

                                                                                           Communiqué de presseLesquin, 22 juin 2020, 18h00NACON A INTÉGRÉ LES INDICES EURONEXT CAC SMALL, CAC MID & SMALL ET CAC ALL-TRADABLE DEPUIS LE 19 JUIN 2020NACON (ISIN FR0013482791), acteur intégré du jeu vidéo en forte croissance, a été introduit en bourse sur le marché règlementé d’Euronext Paris (Eurolist ,Compartiment B) le 4 mars 2020.La société a été informée par Euronext qu’à la suite de la révision trimestrielle des indices Euronext Paris en date du 11 juin 2020, le Conseil Scientifique des Indices, a pris la décision d’admettre NACON dans les échantillons composant les indices CAC® Small, CAC® Mid & Small et CAC® All-Tradable.Prochain rendez-vous :Chiffre d’affaires du 1er trimestre 2020/21 : 27 juillet 2020Communiqué après Bourse Pièce...

Continue reading

Verkkokauppa.com Oyj: Share repurchase 22 June 2020

Verkkokauppa.com Oyj     Stock Exchange Release       22 June 2020 at 19:00 EETVerkkokauppa.com Oyj: Share repurchase 22 June 2020On Nasdaq HelsinkiCompany now holds a total of 287,151 sharesincluding the shares repurchased on 22 June 2020.On behalf of Verkkokauppa.com OyjDANSKE BANK AS, SUOMEN SIVULIIKE For more information, please contact:Mikko Forsell, CFOmikko.forsell@verkkokauppa.comPuh. +358 10 309 5555AttachmentVerkkokauppa.com Oyj Share repurchases 22.6

Continue reading

Verkkokauppa.com Oyj: Omien osakkeiden hankinta 22.6.2020

Verkkokauppa.com Oyj         Pörssitiedote               22.6.2020 klo 19.00Verkkokauppa.com Oyj: Omien osakkeiden hankinta 22.6.2020Nasdaq HelsinkiYhtiön hallussa olevat omat osakkeet 22.6.2020tehtyjen kauppojen jälkeen: 287 151 KPL.Verkkokauppa.com Oyj:n puolestaDANSKE BANK AS, SUOMEN SIVULIIKEJonathan Nyberg           Antti Väliaho Lisätietoja:Mikko Forsell, Talousjohtajamikko.forsell@verkkokauppa.comPuh. +358 10 309 5555LiiteVerkkokauppa.com Oyj Share repurchases 22.6

Continue reading

Saniona raises SEK 22 million through sales of shares in Scandion Oncology

PRESS RELEASE22 June, 2020Saniona (OMX: SANION), a clinical-stage biotech company focused on rare diseases, today announced that it has raised SEK 22 million (USD 2.3 million) through the sale of shares in Scandion Oncology A/S (Spotlight Stock Market: SCOL).Saniona sold 754,577 shares of Scandion Oncology. The sale of shares brings Saniona’s ownership stake in Scandion Oncology below 15%. Proceeds will be used to continue Saniona’s advancement of mid/late-stage clinical trials with Tesomet in two rare eating disorders: hypothalamic obesity (HO) and Prader Willi Syndrome (PWS), as well as to build its U.S.-based leadership team in support of these programs.“Saniona continues to tighten our focus on building a global, commercial-stage rare disease company, which will require significant capital investment over the next few years” said...

Continue reading

Saniona tar in 22 MSEK genom försäljning av aktier i Scandion Oncology

PRESSMEDDELANDE22 juni 2020Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att företaget tagit in 22 MSEK (2,3 MUSD) genom försäljning av aktier i Scandion Oncology A/S (Spotlight Stock Market: SCOL).Saniona sålde 754 577 aktier i Scandion Oncology. I och med aktieförsäljningen blir Sanionas ägarandel i Scandion Oncology mindre än 15 procent. Försäljningslikviden kommer att användas till att fortsätta avancera Sanionas kliniska läkemedelsprövningar av Tesomet mot två sällsynta ätstörningar, hypotalamisk fetma (HO) och Prader-Willis syndrom (PWS), som för närvarande är i mellanfas och sen fas, samt för att understödja de kliniska utvecklingsprogrammen genom att bygga upp den USA-baserade ledningsgruppen.”Saniona fortsätter att rikta in sitt fokus på att etablera...

Continue reading

EGIDE : Résultats des votes de l’Assemblée Générale Mixte du 19 juin 2020

Communiqué de presseRésultats des votes de l’Assemblée Générale Mixte du 19 juin 2020Bollène, le 22 juin 2020 – 18 :00 (CET) – La société Egide informe ses actionnaires que l’Assemblée Générale Mixte s’est réunie comme prévu le vendredi 19 juin 2020 à 14h00.En raison du contexte de la pandémie du Covid-19, elle a eu lieu à huis clos au siège social du Groupe sous la présidence de Monsieur Eric Delmas, Directeur général Adjoint du Groupe Egide.Cette Assemblée s’étant tenue hors la présence physique des actionnaires, ceux-ci avaient été invités à voter par correspondance ou à donner pouvoir au Président de l’Assemblée.Les actionnaires présents ou représentés détenaient 3 405 780 actions (soit 32,92 % sur un total de 10.346.868 actions ayant droit de vote à la date de l’Assemblée) et 3 409 480 voix (soit 32,77 % sur un total...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.